Cellosaurus A549-hACE2 [BEI resources] (CVCL_A7UV)
| Cell line name | A549-hACE2 [BEI resources] | |
|---|---|---|
| Accession | CVCL_A7UV | |
| Resource Identification Initiative | To cite this cell line use: A549-hACE2 [BEI resources] (RRID:CVCL_A7UV) | |
| Comments | Group: SARS-CoV-2 research cell line. From: Baric, Ralph Steven; Department of Epidemiology, University of North Carolina at Chapel Hill; Chapel Hill; USA. Population: Caucasian. Characteristics: Expresses ACE2 under the control of the EF1a promoter (BEI_Resources=NR-53821). Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr. Derived from site: In situ; Lung; UBERON=UBERON_0002048. | |
| Sequence variations |
| |
| Disease | Lung adenocarcinoma (NCIt: C3512) | |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | |
| Hierarchy | Parent: CVCL_0023 (A-549) Children:
| |
| Sex of cell | Male | |
| Age at sampling | 58Y | |
| Category | Cancer cell line | |
| Cross-references | ||
| Cell line collections (Providers) | BEI_Resources; NR-53821 | |
| Cell line databases/resources | cancercelllines; CVCL_A7UV | |
| Encyclopedic resources | Wikidata; Q107113334 | |
| Entry history | ||
| Entry creation | 20-May-2021 | |
| Last entry update | 14-Aug-2025 | |
| Version number | 8 | |